Impact of prior anthracycline or taxane use on eribulin effectiveness as first-line treatment for metastatic breast cancer: results from two phase 2, multicenter, single-arm studies
Crossref DOI link: https://doi.org/10.1186/s40064-015-1322-y
Published Online: 2015-09-21
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
O’Shaughnessy, Joyce
McIntyre, Kristi
Schwartzberg, Lee
Wilks, Sharon
Puhalla, Shannon
Berrak, Erhan
Song, James
Vahdat, Linda
License valid from 2015-09-21